• Transplantation of stem and progenitor cells in the long term for correction of the consequences of hypoxic-ischemic encephalopathy of newborn babies

Transplantation of stem and progenitor cells in the long term for correction of the consequences of hypoxic-ischemic encephalopathy of newborn babies

HEALTH OF WOMAN. 2016.10(116):110–120

Transplantation of stem and progenitor cells in the long term for correction of the consequences of hypoxic-ischemic encephalopathy of newborn babies

Veropotvelyan P. N., Tsehmistrenko I. S., Veropotvelyan N. P., Guzhevskaya I. V., Zhabitska L. A., Zhuravleva C. A. 
«Interregional centre of medical genetics and prenatal diagnosis», Krivoy Rog
 
Perinatal center, Kiev
 
National medical University named after O. O. Bogomolets, Kyiv

The review included the results of the mechanism of therapeutic action of stem cells in cerebral disorders in newborn babies. 
The results of the review of foreign publications to analyze different aspects of cell therapy, from the type of stem cells and sources. Studied the components that determine the positive effect in relation to the treatment of ischemia/hypoxia of the brain.
Shown high therapeutic efficiency of cellular technologies and the prospects of their application in neonatology. However, it is necessary to study this problem, aimed at a comprehensive characterization of cell type and dose, the optimal time and method of their conduct for the most effective application of cell therapy.

Key words: stem cells, newborn infants, hypoxic-ischemic encephalopathy, asphyxia.

REFERENCES

1. Ali JM, Bolton EM, Bradley JA, Pettigrew GJ. 2013. Allorecognition pathways in transplant rejection and tolerance. Transplantation 96(8):681-8. https://doi.org/10.1097/TP.0b013e31829853ce; PMid:23715047

2. Antonov AG, Ionov OV, Kirtbaya AR, Balashova EN, Nikitina IV, Ryndin AY, Miroschnik EV, Degtyarev DN. 2014. The methodology of therapeutic hypothermia to children born in a state of asphyxia. Anesthesiology and Intensive Care 59(6):76-7.

3. Ashwal S, Ghosh N, Turenius CI, Dulcich M, Denham CM, Tone B et al. 2014. Reparative effects of neural stem cells in neonatal rats with hypoxic-ischemic injury are not influenced by host sex. Pediatr. Res. 75(5):603-11. https://doi.org/10.1038/pr.2014.7; PMid:24463490 PMCid:PMC4404035

4. Bae SH, Kong TH, Lee HS, Kim KS, Hong KS, Chopp M et al. 2012. Long-lasting paracrine effects of human cord blood cells on damaged neocortex in an animal model of cerebral palsy. Cell Transplant. 21(11):2497-515. https://doi.org/10.3727/096368912X640457; PMid:22524897

5. Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg В et al. 2012. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 30(7):1575-8. https://doi.org/10.1002/stem.1118; PMid:22553154

6. Baranov AA, Albitsky VY, Volgina SY, Mendelevich VD. 2001. Premature babies in childhood and adolescence (medical and psychosocial research). M:184.

7. Bohlin K. 2016. Cell-based strategies to reconstitute vital functions in preterm infants with organ failure. Best Pract. Res. Clin. Obstet. Gynecol. 31:99-111. https://doi.org/10.1016/j.bpobgyn.2015.08.012; PMid:26527306

8. Borghesi A, Cova C, Gazzolo D, Stronati M. 2013. Stem cell therapy for neonatal diseases associated with preterm birth. J. Clin. Neonatol. 2(1):1-7. https://doi.org/10.4103/2249-4847.109230; PMid:24027735 PMCid:PMC3761956

9. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. 2004. Central nervous system entry of peripherally infected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 35(10):2385-9. https://doi.org/10.1161/01.STR.0000141680.49960.d7; PMid:15345799

10. Cameron SH, Alwakeel AJ, Goddard L, Hobbs CE, Gowing EK, Barnett ER et al. 2015. Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia. Mol. Cell. Neurosci. 68:56-72. https://doi.org/10.1016/j.mcn.2015.03.019; PMid:25828540

11. Carroll J. 2012. Human cord blood for the hypoxic-ischemic reonate. Pediatric Research. 71:459–463. https://doi.org/10.1038/pr.2011.53; PMid:22278181 PMCid:PMC3640287

12. Chen L, Huang H, Xi H, Xie Z, Liu R, Jiang Z et al. 2010. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial. Cell Transplant. 19(2):185-91. https://doi.org/10.3727/096368910X492652; PMid:20350360

13. Chua JY, Pendharkar AV, Wang N, Choi R, Andres RH, Gaeta X et al. 2011. Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J. Cereb. Blood Flow Metab. 31(5):1263-71. https://doi.org/10.1038/jcbfm.2010.213; PMid:21157474 PMCid:PMC3099630

14. Chou RH, Lu CY, Fan JR, Yu YL, Shyu WC. 2014. The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine. Cell Transplant. 23(4-5):567-71. https://doi.org/10.3727/096368914X678508; PMid:24816451

15. Comi AM, Cho E, Mulholland JD, Hooper A, Li Q, Qu Y et al. 2008. Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr. Neurol. 38(2):86-92. https://doi.org/10.1016/j.pediatrneurol.2007.10.007; PMid:18206788

16. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E et al. 2009. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells. 27(10):2624-35. https://doi.org/10.1002/stem.194; PMid:19676124

17. Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF et al. 2014. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J. Pediatr. 164(5):973-9. e1.

18. Cui LL, Kerkela E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A et al. 2015. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res. Ther. 6:11. https://doi.org/10.1186/scrt544; PMid:25971703 PMCid:PMC4429328

19. Daadi MM, Davis AS, Arac A, Li Z, Maag AL, Bhatnagar R et al. 2010. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke. 41(3):516-23. https://doi.org/10.1161/STROKEAHA.109.573691; PMid:20075340

20. Danielyan L, Schafer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, Klopfer T et al. 2009. Intranasal delivery of cells to the brain. Eur. J. Cell Biol. 88(6):315-24. https://doi.org/10.1016/j.ejcb.2009.02.001; PMid:19324456

21. Davies MW, Swaminathan M, Chuang SL, Betheras FR. 2000. Reference ranges for the linear dimensions of the intracranial ventricles in preterm neonates. Arch. Dis. Child. Fetal Neonatal Ed. 82(3):F218-23. https://doi.org/10.1136/fn.82.3.F218; PMid:10794790 PMCid:PMC1721078

22. Donega V, van Velthoven C, Nijboer C et al. 2013. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS ONE. 8:e51253. https://doi.org/10.1371/journal.pone.0051253; PMid:23300948 PMCid:PMC3536775

23. Donega V, Nijboer CH, van Velthoven CT, Youssef SA, de Bruin A, van Bel F et al. 2015. Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse. Pediatr. Res. 78(5):520-6. https://doi.org/10.1038/pr.2015.145; PMid:26270577 PMCid:PMC4635434

24. Donega V, van Velthoven CT, Nijboer CH, Kavelaars A, Heijnen CJ. 2013. The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J. Cereb. Blood Flow Metab. 33(5):625-34. https://doi.org/10.1038/jcbfm.2013.3; PMid:23403379 PMCid:PMC3652688

25. Donega V, Nijboer CH, van Tilborg G, Dijkhuizen RM, Kavelaars A, Heijnen CJ. 2014. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp. Neurol. 261:53-64. https://doi.org/10.1016/j.expneurol.2014.06.009; PMid:24945601

26. Efimova O. A. Molecular biology for bioinformatics /no10_epigenetika-1.ppt

27. Erices A, Conget P, Minguell JJ. 2000. Mesenchymal progenitor cells in human umbilical cord blood. J. Br. J. Haematol. 109(1):235-42. https://doi.org/10.1046/j.1365-2141.2000.01986.x; PMid:10848804

28. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL et al. 1998. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16(11):1033-9. https://doi.org/10.1038/3473; PMid:9831031

29. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. 2001. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 169(1):12-20. https://doi.org/10.1159/000047856; PMid:11340257

30. Greggio S, de Paula S, Azevedo PN, Venturin GT, Dacosta JC. 2014. Intra-arterial transplantation of human umbilical cord blood mononuclear cells in neonatal hypoxic-ischemic rats. Life Sci. 96(1-2):33-9. https://doi.org/10.1016/j.lfs.2013.10.017; PMid:24177600

31. Guan LX, Guan H, Li HB, Ren CA, Liu L, Chu JJ et al. 2015. Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes. Exp. Ther. Med. 9(5):1623-30. https://doi.org/10.3892/etm.2015.2339

32. Gutierrez-Fernandez M, Rodriguez-Frutos B, Alvarez-Grech J, Vallejo-Cremades MT, Exposito-Alcaide M, Merino J et al. 2011. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience 175:394-405. https://doi.org/10.1016/j.neuroscience.2010.11.054; PMid:21144885

33. Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK. 2008. Intravascular cell replacement therapy for stroke. Neurosurg. Focus. 24(3-4):E15. https://doi.org/10.3171/FOC/2008/24/3-4/E14; PMid:18341391

34. Hass R, Kasper C, Bohm S, Jacobs R. 2011. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 9:12. https://doi.org/10.1186/1478-811X-9-12; PMid:21569606 PMCid:PMC3117820

35. Hirschi KK, Li S, Roy K. 2014. Induced pluripotent stem cells for regenerative medicine. Annu. Rev. Biomed. Eng. 16:277-94. https://doi.org/10.1146/annurev-bioeng-071813-105108; PMid:24905879 PMCid:PMC4287204

36. Hori J, Ng TF, Shatos M, Klassen H, Streilein JW, Young MJ. 2003. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells. 21(4):405-16. https://doi.org/10.1634/stemcells.21-4-405; PMid:12832694

37.http://dbyne.moy.su/news/kogda_vyrastjat_iskusstvennuju_pechen_i_pri_chem_tu/2014-06-25-162

38. http://sciencevsaging.org/content/свободный-/-9

39. http://biofile.ru/bio/19658.html

40. Iguchi A, Terashita Y, Sugiyama M, Ohshima J, Sato TZ, Cho Y et al. 2016. Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation. Pediatr. Transplant. 20(1):114-9. https://doi.org/10.1111/petr.12621; PMid:26526424

41. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD et al. 2004. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA. 101(52):18117-22. https://doi.org/10.1073/pnas.0408258102; PMid:15608062 PMCid:PMC536055

42. Janowski M, Lyczek A, Engels C, Xu J, Lukomska B, Bulte JW et al. 2013. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J. Cereb. Blood Flow Metab. 33(6):921-7. https://doi.org/10.1038/jcbfm.2013.32; PMid:23486296 PMCid:PMC3677113

43. Jansen EM, Solberg L, Underhill S, Wilson S, Cozzari C, Hartman BK et al. 1997. Transplantation of fetal neocortex ameliorates sensorimotor and locomotor deficits following neonatal ischemic-hypoxic brain injury in rats. Exp. Neurol. 147(2):487-97. https://doi.org/10.1006/exnr.1997.6596; PMid:9344572

44. Jin K, Sun Y, Xie L, Mao XO, Childs J, Peel A et al. 2005. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol. Dis. 18(2):366-74. https://doi.org/10.1016/j.nbd.2004.10.010; PMid:15686965

45. Johnston MV, Hagberg H. 2007. Sex and the pathogenesis of cerebral palsy. Dev. Med. Child Neurol. 49(1):74-8. https://doi.org/10.1017/S0012162207000199.x; PMid:17209983

46. Kao CH, Chen SH, Chio CC, Lin MT. 2008. Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock. 29(1):49-55. PMid:17666954

47. Keroll D. 2013. The use of stem cells in hypoxic-ischemic brain damage of newborn pulp. Magazine «cell and organ transplantation» 1(1).

48. Kucia M, Halasa M, Wysoczynski M, Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E et al. 2007. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia. 21(2):297-303. https://doi.org/10.1038/sj.leu.2404470; PMid:17136117

49. Larijani B, Esfahani EN, Amini P, Nikbin B, Alimoghaddam K, Amiri S et al. 2012. Stem cell therapy in treatment of different diseases. Acta Med. Iran. 50(2):79-96. PMid:22359076

50. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 371(9624):1579-86. https://doi.org/10.1016/s0140-6736(08)60690-x

51. Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Li Q et al. 2010. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J. Cereb. Blood Flow Metab. 30(3):653-62. https://doi.org/10.1038/jcbfm.2009.238; PMid:19888287 PMCid:PMC2844252

52. Lin RZ, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM. 2011. Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant. 20(4):515-22. https://doi.org/10.3727/096368910X532729; PMid:20887663 PMCid:PMC3036780

53. Li M, Hale JS, Rich JN, Ransohoff RM, Lathia JD. 2012. Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair. Trends Neurosci. 35(10):619-28. https://doi.org/10.1016/j.tins.2012.06.003; PMid:22784557 PMCid:PMC3461091

54. Luan Z, Yin G, Hu X et al. 2005. Treatment of an infant with severe neonatal hypoxic-ischemic encephalopathy sequelae with transplantation of human neural stem cells into cerebral ventricle. Zhonghua Erke Zazhi. 43:580–583. PMid:16191266

55. Luan Z, Liu W, Qu S et al. 2011. Treatment of newborns with severe injured brain with transplantation of human neural precursor cells. Zhonghua Erke Zazhi. 49:445–449. PMid:21924058

56. Lundberg J, Sodersten E, Sundstrom E, Le Blanc K, Andersson T, Hermanson O et al. 2012. Targeted intra-arterial transplantation of stem cells to the injured CNS is more effective than intravenous administration: engraftment is dependent on cell type and adhesion molecule expression. Cell Transplant. 21(1):333-43. https://doi.org/10.3727/096368911X576036; PMid:21669035

57. Ma L, Zhou Z, Zhang D, Yang S, Wang J, Xue F et al. 2012. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients. Thromb. Haemost. 107(5):937-50. https://doi.org/10.1160/TH11-08-0596; PMid:22398715

58. Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. 2014. Immunobiology of mesenchymal stem cells. Cell Death Differ. 21(2):216-25. https://doi.org/10.1038/cdd.2013.158; PMid:24185619 PMCid:PMC3890955

59. Mancias-Guerra C, Marroquin-Escamilla AR, Gonzalez-Llano O, Villarreal-Martinez L, Jaime-Perez JC, Garcia-Rodriguez F et al. 2014. Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial. Cytotherapy. 16(6):810-20. https://doi.org/10.1016/j.jcyt.2014.01.008; PMid:24642016

60. Meier C, Middelanis J, Wasielewski B et al. 2006. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatric Research. 59:244-249. https://doi.org/10.1203/01.pdr.0000197309.08852.f5; PMid:16439586

61. Misra V, Lal A, El Khoury R, Chen PR, Savitz SI. 2012. Intra-arterial delivery of cell therapies for stroke. Stem Cells Dev. 21(7):1007-15. https://doi.org/10.1089/scd.2011.0612; PMid:22181047 PMCid:PMC3328761

62. Mitsialis SA, Kourembanas S. 2016. Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin. Perinatol. 40(3):138-51. https://doi.org/10.1053/j.semperi.2015.12.002; PMid:26778234 PMCid:PMC4808378

63. Murase S, Horwitz AF. 2002. Deleted in colorectal carcinoma and differentially expressed integrins mediate the directional migration of neural precursors in the rostral migratory stream. J. Neurosci. 22(9):3568-79. PMid:11978833

64. Narogan MV, Vorona LD, Petraki VL, Prityko AG, Simernitsky BP, Romanova RI, Sidorenko EE, Malyutina LV, Petrova A. 2013. Experience of extremely premature infants with intraventricular hemorrhage complicated by progressive hydrocephalus. Russian Vestnik Perinatology and pediatrics 58(3):25-9.

65. Najar M, Raicevic G, Crompot E, Fayyad-Kazan H, Bron D, Toungouz M et al. 2016. The immunomodulatory potential of mesenchymal stromal cells: a story of a regulatory network. J. Immunother. 39(2):45-59. https://doi.org/10.1097/CJI.0000000000000108; PMid:26849074

66. Naujock M, Stanslowsky N, Reinhardt P, Sterneckert J, Haase A, Martin U et al. 2014. Molecular and functional analyses of motor neurons generated from human cord-blood-derived induced pluripotent stem cells. Stem Cells Dev. 23(24):3011-20. https://doi.org/10.1089/scd.2014.0180; PMid:25007389

67. Newell LF, Flowers ME, Gooley TA, Milano F, Carpenter PA, Martin PJ et al. 2013. Characteristics of chronic GVHD after cord blood transplantation. Bone Marrow Transplant. 48(10):1285-90. https://doi.org/10.1038/bmt.2013.48; PMid:23584444 PMCid:PMC3795867

68. Nimgaonkar MT, Roscoe R, Persichetti J, Rybka WB, Winkelstein A, Ball ED. 1995. A unique population of CD34+ cells in cord blood. Stem Cells. 13(2):158-66. https://doi.org/10.1002/stem.5530130207; PMid:7540469

69. Northington FJ. 2006. Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR. J. 47(1):32-8. https://doi.org/10.1093/ilar.47.1.32; PMid:16391429

70. Obenaus A, Dilmac N, Tone B, Tian HR, Hartman R, Digicayliog M et al. 2011. Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Ann. Neurol. 69(2):282-91. https://doi.org/10.1002/ana.22168; PMid:21387373 PMCid:PMC3069664

71. Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. 2001. Cell culture. Progenitor cells from human brain after death. Nature 411(6833):42-3. https://doi.org/10.1038/35075141; PMid:11333968

72. Paula S, Greggio S, Marinowic DR, Machado DC, DaCosta JC. 2012. The dose-response effect of acute intravenous transplantation of human umbilical cord blood cells on brain damage and spatial memory deficits in neonatal hypoxia-ischemia. Neuroscience 210:431-41. https://doi.org/10.1016/j.neuroscience.2012.03.009; PMid:22441035

73. Pendharkar AV, Chua JY, Andres RH, Wang N, Gaeta X, Wang H et al. 2010. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke. 41(9):2064-70. https://doi.org/10.1161/STROKEAHA.109.575993; PMid:20616329 PMCid:PMC4831577

74. Perlman JM. 2006. Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics. 117(3;2):28-33.

75. Poltavtseva RA, Rzhaninova AA, Revishchin AV, Aleksandrova MA, Korochkin LI, Repin VS et al. 2001. In vitro development of neural progenitor cells from human embryos. Bull. Exp. Biol. Med. 132(3):861-3. https://doi.org/10.1023/A:1013170701936; PMid:11740578

76. Poltavtseva RA, Marey MV, Aleksandrova MA, Revishchin AV, Korochkin LI, Sukhikh GT. 2002. Evaluation of progenitor cell cultures from human embryos for neurotransplantation. Brain Res. Dev. Brain Res. 134(1-2):149-54. https://doi.org/10.1016/S0165-3806(02)00274-2

77. Popkov VA, Plotnikov EY, Silachev DN, Zorova LD, Pevzner IB, Jankauskas SS et al. 2015. Diseases and aging: gender matters. Biochemistry (Mosc). 80(12):1560-70. https://doi.org/10.1134/S0006297915120032; PMid:26638680

78. Reinders ME, Dreyer GJ, Bank JR, Roelofs H, Heidt S, Roelen DL et al. 2015. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study. J. Transl. Med. 13:344. https://doi.org/10.1186/s12967-015-0700-0; PMid:26537851 PMCid:PMC4632480

79. Rice J, Vannucci R, Brierly J. 1981. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 9:131–141. https://doi.org/10.1002/ana.410090206; PMid:7235629

80. Rocha V, Wagner JEJr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. 2000. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocard and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N. Engl. J. Med. 342(25):1846-54. https://doi.org/10.1056/NEJM200006223422501; PMid:10861319

81. Rosado-de-Castro PH, Fda R. Schmidt, Battistella V, Lopes de Souza SA, Gutfilen B, Goldenberg RC et al. 2013. Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen. Med. 8(2):145-55. https://doi.org/10.2217/rme.13.2; PMid:23477395

82. Rosenkranz K, Kumbruch S, Lebermann K, Marschner K, Jensen A, Dermietzel R et al. 2010. The chemokine SDF-1/CXCL12 contributes to the ‘homing’ of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. J. Neurosci. Res. 88(6):1223-33. PMid:19937807

83. Santilli G, Lamorte G, Carlessi L, Ferrari D, Rota Nodari L, Binda E et al. 2010. Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS One. 5(1):e8575. https://doi.org/10.1371/journal.pone.0008575; PMid:20052410 PMCid:PMC2797394

84. Silachev DN, Shubina MI, Iankauskas SS, Mkrtchian VP, Manskikh VN, Guliaev MV, Zorov DB. 2013. Evaluation of a long-term sensomotor deficit after neonatal rat brain ischemia/hypoxia. Vyssh Nerv Deiat Im I P Pavlova. 63(3):405-16.

85. Silachev DN, Khailova LS, Babenko VA, Gulyaev MV, Kovalchuk SI, Zorova LD et al. 2014. Neuroprotective effect of glutamate-substituted analog of gramicidin A is mediated by the uncoupling of mitochondria. Biochim. Biophys. Acta. 1840(12):3434-42.

86. Silachev DN, Plotnikov EY, Babenko VA, Danilina TI, Zorov LD, Pevzner IB et al. 2015. Intra-arterial administration of multipotent mesenchymal stromal cells promotes functional recovery of the brain after traumatic brain injury. Bull. Exp. Biol. Med. 159(4):528-33. https://doi.org/10.1007/s10517-015-3009-3; PMid:26388566

87. Schu S, Nosov M, O’Flynn L, Shaw G, Treacy O, Barry F et al. 2012. Immunogenicity of allogeneic mesenchymal stem cells. J. Cell. Mol. Med. 16(9):2094-103. https://doi.org/10.1111/j.1582-4934.2011.01509.x; PMid:22151542 PMCid:PMC3822979

88. Shea KL, Palanisamy A. 2015. What can you do to protect the newborn brain? Curr. Opin. Anaesthesiol. 28(3):261-6. https://doi.org/10.1097/ACO.0000000000000184; PMid:25827279

89. Shipounova IN, Petinati NA, Bigildeev AE, Zezina EA, Drize NI, Kuzmina LA et al. 2014. Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation. Biochemistry (Mosc). 79(12):1363-70. https://doi.org/10.1134/S0006297914120104; PMid:25716730

90. Sukhikh GT, Silachyov DN, Pevzner IB, Zorova LD, Babenko VA, Popkov VA, Yankausjkas SS, Zubkov VV, Zorov DB, Plotnikov EYu. 2015. Prospects for using stem and progenitor cells in the therapy of consequences of neonatal hypoxic-ischemic encephalopathy. Obstetrics and gynecology 5:55-66.

91. Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, Wease S et al. 2010. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion. 50(9):1980-7. https://doi.org/10.1111/j.1537-2995.2010.02720.x; PMid:20546200 PMCid:PMC3816574

92. Svendsen CN, Caldwell MA, Ostenfeld T. 1999. Human neural stem cells: isolation, expansion and transplantation. Brain Pathol. 9(3):499-513. https://doi.org/10.1111/j.1750-3639.1999.tb00538.x; PMid:10416990

93. Takahashi M, Vattanajun A, Umeda T, Isa K, Isa T. 2009. Large-scale reorganization of corticofugal fibers after neonatal hemidecortication for functional restoration of forelimb movements. Eur. J. Neurosci. 30(10):1878-87. https://doi.org/10.1111/j.1460-9568.2009.06989.x; PMid:19895560

94. Takahashi K, Yamanaka S. 2013. Induced pluripotent stem cells in medicine and biology. Development. 140:2257–2267. https://doi.org/10.1242/dev.092551; PMid:23715538

95. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H et al. 2004. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114(3):330-8. https://doi.org/10.1172/JCI200420622; PMid:15286799 PMCid:PMC484977

96. Thorne RG, Frey WH. 2001. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. 2nd. Clin. Pharmacokinet. 40(12):907-46. https://doi.org/10.2165/00003088-200140120-00003; PMid:11735609

97. Titomanlio L, Kavelaars A, Dalous J, Mani S, Ghouzzi V, Heijnen C et al. 2011. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann. Neurol. 70(5):698-712. https://doi.org/10.1002/ana.22518

98. Uccelli A. 2013. Mesenchymal stem cells exert a remarkable regenerative effect requiring minimal CNS integration: commentary on: «Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function» by Voulgari-Kokota et al. Exp. Neurol. 247:292-5. https://doi.org/10.1016/j.expneurol.2013.01.028; PMid:23384664

99. Van Velthoven C, Kavelaars A, van Bel F, Heijnen C. 2010. Nasal administration of stem cells: a promising novel route for ischemic brain damage. Pediatric Research 68:419–422. https://doi.org/10.1203/pdr.0b013e3181f1c289

100. Van Velthoven C, Kavelaars A, Heijnen C. 2012. Mesenchymal stem cells as a treatment for neonatal ischemia. Pediatric Research. 71:474–481. https://doi.org/10.1038/pr.2011.64; PMid:22430383

101. Verina T, Fatemi A, Johnston MV, Comi AM. 2013. Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury. Pediatr. Neurol. 48(5):346-54. https://doi.org/10.1016/j.pediatrneurol.2012.10.010

102. Wang Y, Deng Y, Zhou GQ. 2008. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 1195:104-12. https://doi.org/10.1016/j.brainres.2007.11.068; PMid:18206136

103. Wang D, Zhang H, Liang J, Li X, Feng X, Wang H et al. 2013. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 22(12):2267-77. PMid:24388428

104. Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y et al. 2016. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton’s jelly as sources of cell immunomodulatory therapy. Hum. Vaccin. Immunother. 12(1):85-96. https://doi.org/10.1080/21645515.2015.1030549; PMid:26186552 PMCid:PMC4962749

105. Wang X, Zhao Y, Wang X. 2014. Umbilical cord blood cells regulate the differentiation of endogenous neural stem cells in hypoxic ischemic neonatal rats via the hedgehog signaling pathway. Brain Res. 1560:18-26. https://doi.org/10.1016/j.brainres.2014.02.019; PMid:24565927

106. Wasielewski B, Jensen A, Roth-Harer A et al. 2012. Neuroglial activation and CX43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury. Brain Research 1487:39–53. https://doi.org/10.1016/j.brainres.2012.05.066; PMid:22796290

107. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S et al. 2003. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 73(3):296-307. https://doi.org/10.1002/jnr.10659; PMid:12868063

108. Yasuhara T, Matsukawa N, Yu G, Xu L, Mays RW, Kovach J et al. 2006. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant. 15(3):231-8. https://doi.org/10.3727/000000006783982034; PMid:16719058

109. Yoo SW, Chang DY, Lee HS, Kim GH, Park JS, Ryu BY et al. 2013. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-beta. Neurobiol. Dis. 58:249-57. https://doi.org/10.1016/j.nbd.2013.06.001; PMid:23759293

110. Zhang X, Zhang Q, Li W, Nie D, Chen W, Xu C et al. 2014. Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy. J. Neurosci. Res. 92(1):35-45. https://doi.org/10.1002/jnr.23304; PMid:24265136

111. Zhang R, Liu Y, Yan K, Chen L, Chen XR, Li P et al. 2013. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J. Neuroinflammation. 10:106. https://doi.org/10.1186/1742-2094-10-106; PMid:23971414 PMCid:PMC3765323

112. Zhao L, Duan W, Reyes M et al. 2002. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Experimental Neurology 174:11–20. https://doi.org/10.1006/exnr.2001.7853; PMid:11869029

113. Zwijnenburg PJ, van der Poll T, Florquin S, van Deventer SJ, Roord JJ, van Furth AM. 2001. Experimental pneumococcal meningitis in mice: a model of intranasal infection. J. Infect. Dis. 183(7):1143-6. https://doi.org/10.1086/319271; PMid:11237845